These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Early atrophy of pallidum and accumbens nucleus in Huntington's disease. van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA, TRACK-HD Investigator Group. J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300 [Abstract] [Full Text] [Related]
4. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC, TRACK-HD Investigators. Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037 [Abstract] [Full Text] [Related]
5. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study. van den Bogaard SJ, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos RA. J Neurol Sci; 2011 Aug 15; 307(1-2):60-8. PubMed ID: 21624624 [Abstract] [Full Text] [Related]
6. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Aylward EH, Li Q, Stine OC, Ranen N, Sherr M, Barta PE, Bylsma FW, Pearlson GD, Ross CA. Neurology; 1997 Feb 15; 48(2):394-9. PubMed ID: 9040728 [Abstract] [Full Text] [Related]
7. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease. Coppen EM, Jacobs M, van den Berg-Huysmans AA, van der Grond J, Roos RAC. Parkinsonism Relat Disord; 2018 Jan 15; 46():56-61. PubMed ID: 29128164 [Abstract] [Full Text] [Related]
8. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease. Gargouri F, Messé A, Perlbarg V, Valabregue R, McColgan P, Yahia-Cherif L, Fernandez-Vidal S, Ben Hamida A, Benali H, Tabrizi S, Durr A, Lehéricy S. Hum Brain Mapp; 2016 Nov 15; 37(11):4112-4128. PubMed ID: 27400836 [Abstract] [Full Text] [Related]
10. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling. Finegan E, Li Hi Shing S, Chipika RH, Doherty MA, Hengeveld JC, Vajda A, Donaghy C, Pender N, McLaughlin RL, Hardiman O, Bede P. Neuroimage Clin; 2019 Nov 15; 24():102089. PubMed ID: 31795059 [Abstract] [Full Text] [Related]
11. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis. Scahill RI, Zeun P, Osborne-Crowley K, Johnson EB, Gregory S, Parker C, Lowe J, Nair A, O'Callaghan C, Langley C, Papoutsi M, McColgan P, Estevez-Fraga C, Fayer K, Wellington H, Rodrigues FB, Byrne LM, Heselgrave A, Hyare H, Sampaio C, Zetterberg H, Zhang H, Wild EJ, Rees G, Robbins TW, Sahakian BJ, Langbehn D, Tabrizi SJ. Lancet Neurol; 2020 Jun 15; 19(6):502-512. PubMed ID: 32470422 [Abstract] [Full Text] [Related]
12. Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study. Odish OF, van den Berg-Huysmans AA, van den Bogaard SJ, Dumas EM, Hart EP, Rombouts SA, van der Grond J, Roos RA, TRACK-HD Investigator Group. Hum Brain Mapp; 2015 Jan 15; 36(1):110-9. PubMed ID: 25139578 [Abstract] [Full Text] [Related]
13. Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials. Müller HP, Huppertz HJ, Dreyhaupt J, Ludolph AC, Tabrizi SJ, Roos RAC, Durr A, Landwehrmeyer GB, Kassubek J. Parkinsonism Relat Disord; 2019 Jun 15; 63():179-184. PubMed ID: 30846243 [Abstract] [Full Text] [Related]
14. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P, Remy P. Neuroimage; 2006 Oct 01; 32(4):1562-75. PubMed ID: 16875847 [Abstract] [Full Text] [Related]
15. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study. Georgiou-Karistianis N, Gray MA, Domínguez D JF, Dymowski AR, Bohanna I, Johnston LA, Churchyard A, Chua P, Stout JC, Egan GF. Neurobiol Dis; 2013 Mar 01; 51():82-92. PubMed ID: 23069680 [Abstract] [Full Text] [Related]
16. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. Harris GJ, Aylward EH, Peyser CE, Pearlson GD, Brandt J, Roberts-Twillie JV, Barta PE, Folstein SE. Arch Neurol; 1996 Apr 01; 53(4):316-24. PubMed ID: 8929153 [Abstract] [Full Text] [Related]